{"text": ["After", "Hours", "Most", "Active", "for", "Dec", "21,", "2018", ":", "", "CSCO,", "BAC,", "MSFT,", "XOM,", "AAPL,", "GE,", "PFE,", "QQQ,", "MBI,", "MU,", "KGC,", "FB"], "created_at": "2018-12-21 22:36:58"}
{"text": ["After", "Hours", "Most", "Active", "for", "Dec", "21,", "2018", ":", "", "CSCO,", "BAC,", "MSFT,", "XOM,", "AAPL,", "GE,", "PFE,", "QQQ,", "MBI,", "MU,", "KGC,", "FB"], "created_at": "2018-12-21 22:36:58"}
{"text": ["AbbVie", "(ABBV)", "Seeks", "Approval", "for", "RA", "Candidate", "Upadacitinib"], "created_at": "2018-12-21 22:06:56"}
{"text": ["AbbVie", "(ABBV)", "Seeks", "Approval", "for", "RA", "Candidate", "Upadacitinib"], "created_at": "2018-12-21 22:06:56"}
{"text": ["Pfizer", "and", "GlaxoSmithKline\u2019s", "Joint", "Venture:", "What", "to", "Expect"], "created_at": "2018-12-21 20:00:02"}
{"text": ["Merck", "KGaA-Pfizer", "to", "end", "late-stage", "ovarian", "cancer", "treatment", "study"], "created_at": "2018-12-21 19:55:13"}
{"text": ["AbbVie", "(ABBV)", "Seeks", "Approval", "for", "RA", "Candidate", "Upadacitinib"], "created_at": "2018-12-21 19:52:07"}
{"text": ["Do", "Analysts", "See", "Any", "Upside", "for", "Sarepta", "Stock?"], "created_at": "2018-12-21 19:03:41"}
{"text": ["Analyzing", "Sarepta", "Therapeutics\u2019", "Gross", "Margin", "Trends"], "created_at": "2018-12-21 19:03:40"}
{"text": ["Taking", "Stock", "of", "Sarepta\u2019s", "Latest", "Performance"], "created_at": "2018-12-21 19:03:40"}
{"text": ["Understanding", "Sarepta", "Therapeutics\u2019", "Operational", "Performance"], "created_at": "2018-12-21 19:03:40"}
{"text": ["Merck", "KGaA,", "Darmstadt,", "Germany,", "and", "Pfizer", "Provide", "Update", "on", "JAVELIN", "Ovarian", "100", "Trial", "of", "Avelumab", "in", "Previously", "Untreated", "Advanced", "Ovarian", "Cancer"], "created_at": "2018-12-21 19:00:00"}
{"text": ["Pfizer", "and", "GlaxoSmithKline\u2019s", "Consumer", "Health", "Business"], "created_at": "2018-12-21 18:30:13"}
{"text": ["Pfizer", "Xtandi", "Succeeds", "in", "Late-Stage", "Prostate", "Cancer", "Study"], "created_at": "2018-12-21 17:10:58"}
{"text": ["Pfizer", "Xtandi", "Succeeds", "in", "Late-Stage", "Prostate", "Cancer", "Study"], "created_at": "2018-12-21 17:10:58"}
{"text": ["Pfizer", "and", "GlaxoSmithKline", "Form", "a", "Joint", "Venture"], "created_at": "2018-12-21 16:55:39"}
{"text": ["Former", "P&G", "manager", "named", "CEO", "of", "$12B", "joint", "venture"], "created_at": "2018-12-21 16:21:23"}
{"text": ["Pharma", "Stock", "Roundup:", "GSK,", "PFE", "Ink", "Consumer", "Health", "JV,", "JNJ", "Hit", "by", "Talc", "Allegations"], "created_at": "2018-12-21 16:11:46"}
{"text": ["Pharma", "Stock", "Roundup:", "GSK,", "PFE", "Ink", "Consumer", "Health", "JV,", "JNJ", "Hit", "by", "Talc", "Allegations"], "created_at": "2018-12-21 16:11:46"}
{"text": ["GlaxoSmithKline", "Capital", "Inc.", "--", "Moody's", "affirms", "GSK's", "A2", "ratings;", "outlook", "remains", "negative"], "created_at": "2018-12-21 15:26:09"}
{"text": ["Pfizer", "Xtandi", "Succeeds", "in", "Late-Stage", "Prostate", "Cancer", "Study"], "created_at": "2018-12-21 14:31:02"}
{"text": ["Pharma", "Stock", "Roundup:", "GSK,", "PFE", "Ink", "Consumer", "Health", "JV,", "JNJ", "Hit", "by", "Talc", "Allegations"], "created_at": "2018-12-21 14:13:02"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Proteostasis", "Delays", "Data,", "Akron", "Gets", "New", "CEO,", "Pfizer", "Halts", "Vaccine", "Trial"], "created_at": "2018-12-21 12:58:02"}
{"text": ["[$$]", "European", "Equities", "Market", "Talk", "Roundup"], "created_at": "2018-12-21 08:54:02"}
{"text": ["Pfizer", "Discontinues", "Phase", "2b", "STRIVE", "Clinical", "Trial", "Due", "To", "Futility"], "created_at": "2018-12-21 00:12:00"}
{"text": ["Pfizer", "Discontinues", "Phase", "2b", "STRIVE", "Clinical", "Trial", "Due", "To", "Futility"], "created_at": "2018-12-21 00:12:00"}
